Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hypertrophic obstructive cardiomyopathy: surgical therapy].

H D Schulte1, W Bircks, B Lösse

  • 1Abteilung für Thorax- und Kardiovaskuläre Chirurgie, Universität Düsseldorf.

Fortschritte Der Medizin
|September 30, 1992
PubMed
Summary

Surgical myectomy for hypertrophic obstructive cardiomyopathy (HOCM) offers improved outcomes. This surgery is recommended for symptomatic HOCM patients unresponsive to drug therapy, demonstrating reduced mortality and enhanced physical performance post-operation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Considering milk price volatility for investment decisions on the farm level after European milk quota abolition.

Journal of dairy science·2018
Same author

Intermittent aortic cross-clamping for coronary artery bypass grafting: a review of a safe, fast, simple, and successful technique.

The Journal of cardiovascular surgery·2005
Same author

History of cardiac surgery in Germany--in consideration of her relation to the German Cardiac Society.

Zeitschrift fur Kardiologie·2002
Same author

Myocardial collagen type I and impaired left ventricular function under exercise in hypertrophic cardiomyopathy.

The Thoracic and cardiovascular surgeon·2002
Same author

Elastase release following myocardial ischemia during extracorporeal circulation (ECC) -- marker of ongoing systemic inflammation?

The Thoracic and cardiovascular surgeon·2002
Same author

Myocardial revascularization in patients with end-stage renal disease: comparison of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting.

International urology and nephrology·2002

Area of Science:

  • Cardiovascular Surgery
  • Cardiology
  • Medical Treatment

Context:

  • Hypertrophic obstructive cardiomyopathy (HOCM) is a condition requiring intervention when drug therapy fails.
  • Surgical treatment, specifically transaortic subvalvular myectomy (TSM), has been utilized for decades.
  • Patients often present with severe symptoms (NYHA class III or IV).

Purpose:

  • To report outcomes of surgical myectomy in a large cohort of HOCM patients.
  • To evaluate the safety and efficacy of transaortic subvalvular myectomy (TSM).
  • To assess long-term survival and symptom improvement after surgery.

Summary:

  • A retrospective analysis of 353 HOCM patients undergoing transaortic subvalvular myectomy (TSM) between 1963 and 1991.
  • Overall hospital mortality was 4.8%, with lower rates for TSM alone (3.1%) compared to combination surgery (9.8%).

Related Experiment Videos

  • Recent data (since 1984) show improved mortality rates (2.06%), with long-term follow-up indicating better symptoms, physical performance, and lower annual mortality (1.1%) compared to drug-treated patients (1.8-4%).

    • Impact:

    • Surgical myectomy is a viable and recommended option for symptomatic HOCM patients refractory to medical management.
    • The procedure leads to significant improvements in patient quality of life and physical capacity.
    • Refined surgical techniques have progressively reduced operative mortality, enhancing the procedure's overall benefit-risk profile.